About Morphle
Morphle is a company based in Bengaluru (India) founded in 2017.. Morphle has raised $5.15 million across 3 funding rounds from investors including HealthVenture, Y Combinator and Inflexor. Morphle offers products and services including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16. Morphle operates in a competitive market with competitors including Akoya Biosciences, Scopio Labs, PreciPoint, Optra SCAN and Grundium, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Morphle Labs Private Limited
- Date of Incorporation 08 Jan, 2020
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$1.33 M (USD)164.29as on Mar 31, 2023
-
Net Profit
$-10.57 K (USD)72.23as on Mar 31, 2023
-
EBITDA
$10.14 K (USD)133.24as on Mar 31, 2023
-
Total Equity Funding
$5.15 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Nov 25, 2025
-
Investors
HealthVenture
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Morphle
Morphle offers a comprehensive portfolio of products and services, including Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates tissue sectioning for high-throughput pathology
Scans single slides for tissue and cytology applications
Handles up to 100 slides daily for digital microscopy
Processes high-volume batches for histopathology workflows
Specialized for hematology and bone marrow analysis
Unlock access to complete
Funding Insights of Morphle
Morphle has successfully raised a total of $5.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $5.0M
-
First Round
First Round
(17 Mar 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series A - Morphle | Valuation | Inflexor |
|
| Sep, 2021 | Amount | Grant - Morphle | Valuation |
investors |
|
| Mar, 2020 | Amount | Seed - Morphle | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Morphle
Morphle has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HealthVenture, Y Combinator and Inflexor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare focused incubator and VC firm
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology and deep tech startups with a focus on innovative solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Morphle
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Morphle
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Morphle Comparisons
Competitors of Morphle
Morphle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akoya Biosciences, Scopio Labs, PreciPoint, Optra SCAN and Grundium, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of solutions for rapid proteomic profiling
|
|
| domain | founded_year | HQ Location |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| domain | founded_year | HQ Location |
Digital microscopes and micro-positioning systems are developed.
|
|
| domain | founded_year | HQ Location |
Integrated digital pathology solutions.
|
|
| domain | founded_year | HQ Location |
Portable scanning microscopes are supplied for medical researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Morphle
Frequently Asked Questions about Morphle
When was Morphle founded?
Morphle was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Morphle located?
Morphle is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Is Morphle a funded company?
Morphle is a funded company, having raised a total of $5.15M across 3 funding rounds to date. The company's 1st funding round was a Seed of $150K, raised on Mar 17, 2020.
What is the annual revenue of Morphle?
Annual revenue of Morphle is $1.33M as on Mar 31, 2023.
What does Morphle do?
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
Who are the top competitors of Morphle?
Morphle's top competitors include Akoya Biosciences, Optra SCAN and Scopio Labs.
What products or services does Morphle offer?
Morphle offers Robotic Microtome, MorphoLens 1, MorphoLens 6, MorphoLens 240, and HemoLens 16.
Who are Morphle's investors?
Morphle has 3 investors. Key investors include HealthVenture, Y Combinator, and Inflexor.